US Supreme Court Rejects Pfizer Prempro Appeal


In a blow to the drugmaker, the US Supreme Court rejected a bid by Pfizer to appeal a $58 million damages award made four years ago to three Nevada women, who claimed they suffered breast cancer after taking the Prempro hormone replacement therapy made by its Wyeth unit. The decision comes after the Nevada Supreme Court last November upheld the earlier decision.

Click HERE to read more on this story as reported in the news.

Fibromyalgia Disability: Is There Any Hope?

Dr. Gordon D. Ko

When fibromyalgia syndrome (FMS) is disabling and severe, a multidisciplinary approach is needed, combin- ing tailored non-pharmacological and pharmacological treatments to manage pain, secondary symptoms and functional restoration.

In his paper Fibromyalgia Disability: Is There Any Hope?, Dr. Gordon D. Ko demonstrates significant improvement with functional medicine and bioidentical hormone replacement therapy (BHRT).

HRT May Reduce Risk of Peripheral Artery Disease


THURSDAY, June 16 (HealthDay News) -- The use of hormone replacement therapy (HRT) appears to help protect postmenopausal women against the development of peripheral artery disease, new research indicates.

The risk reduction for peripheral artery disease, or PAD, was found even though the group of women on HRT were more likely to have conditions such as high cholesterol and high blood pressure, the researchers reported.

Off-label marketing: How testosterone replacement got big

By Chris Adams, McClatchy Newspapers

WASHINGTON — The question for doctors was simple: "When a patient comes in and asks for Viagra, will you first screen for low T?" meaning testosterone.

The pitch by Solvay Pharmaceuticals Inc. was part of its effort to make its testosterone replacement drug AndroGel "ride (the) coat tails of Viagra."

But unlike Viagra, AndroGel wasn't approved by the Food and Drug Administration to treat erectile dysfunction.

Menopause Experts Back Hormone Therapy


June 10, 2011 -- The message was clear from the International Menopause Society – Hormone Replacement Therapy (HRT) is safe for most women in menopause but that tr

Comment: Are the problems with Actos and Avandia due to drug company greed or a broken system?

Kent Holtorf, M.D.

John Gever, Senior Editor of MedPage Today recently publish an artitle entitled Cancer Risk Forces Actos Off French, German Markets. In it he reports drug regulators in Germany and France have ordered doctors to stop prescribing the type 2 diabetes drug pioglitazone (Actos) following a French study suggesting a heightened risk of bladder cancer.


Some Postmenopausal Women Not on HRT Have Endometrial Lining Suspicious for Polyps

Alice Goodman, Elsevier Global Medical News

WASHINGTON (EGMN) – A small but important percentage of postmenopausal women not taking hormone replacement therapy have an endometrial lining that is suspicious for polyps, according to a prospective study of 1,500 consecutive asymptomatic women.

FDA restricts use of simvastatin 80 mg


The Food and Drug Administration is recommending that physicians restrict prescribing high-dose simvastatin (Zocor, Merck) to patients, given an increased risk of muscle damage [1]. The new FDA drug safety communication, issued today, states that physicians should limit using the 80-mg dose unless the patient has already been taking the drug for 12 months and there is no evidence of myopathy.

Click HERE to read the full FDA safety communication.

Related Articles:

ENDO: Estrogen Levels Pre-HRT Speak to Heart Risk

Kristina Fiore, Staff Writer, MedPage Today

June 7, 2011 Boston -- Women who have higher levels of endogenous estrogen before starting hormone therapy appear to have a lower risk of heart disease, according to a subgroup analysis of the Women's Health Initiative (WHI) data reported here.



BHI Online houses an archive of hormone-related citations for biomedical literature. Also provided are links to PubMed and the NCBI molecular biology resources.


BHI Online strives to support healthcare professionals through webinars presented by leading experts in their respective fields.


Join the conversation with BHI Online's forums aimed at providing information through communities.

Latest News

A selection of stories and articles making headlines in the field of Bioidentical Hormone therapies.

Get In Touch

Locate a BHRT doctor, submit an article or just say hello, we'd love to meet you.

Sub Page: Side Block 1

Sub Page: Side Block 2

Sub Page: Side Block 3

Sub Page: Side Block 4